171 related articles for article (PubMed ID: 25415718)
1. Implications of CISNET modeling on number needed to screen and mortality reduction with digital mammography in women 40-49 years old.
Hendrick RE; Helvie MA; Hardesty LA
AJR Am J Roentgenol; 2014 Dec; 203(6):1379-81. PubMed ID: 25415718
[TBL] [Abstract][Full Text] [Related]
2. Mammography screening: a new estimate of number needed to screen to prevent one breast cancer death.
Hendrick RE; Helvie MA
AJR Am J Roentgenol; 2012 Mar; 198(3):723-8. PubMed ID: 22358016
[TBL] [Abstract][Full Text] [Related]
3. United States Preventive Services Task Force screening mammography recommendations: science ignored.
Hendrick RE; Helvie MA
AJR Am J Roentgenol; 2011 Feb; 196(2):W112-6. PubMed ID: 21257850
[TBL] [Abstract][Full Text] [Related]
4. Clinical outcomes of modelling mammography screening strategies.
Yaffe MJ; Mittmann N; Lee P; Tosteson AN; Trentham-Dietz A; Alagoz O; Stout NK
Health Rep; 2015 Dec; 26(12):9-15. PubMed ID: 26676234
[TBL] [Abstract][Full Text] [Related]
5. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
[TBL] [Abstract][Full Text] [Related]
6. Comparison of recommendations for screening mammography using CISNET models.
Arleo EK; Hendrick RE; Helvie MA; Sickles EA
Cancer; 2017 Oct; 123(19):3673-3680. PubMed ID: 28832983
[TBL] [Abstract][Full Text] [Related]
7. Collaborative Modeling to Compare Different Breast Cancer Screening Strategies: A Decision Analysis for the US Preventive Services Task Force.
Trentham-Dietz A; Chapman CH; Jayasekera J; Lowry KP; Heckman-Stoddard BM; Hampton JM; Caswell-Jin JL; Gangnon RE; Lu Y; Huang H; Stein S; Sun L; Gil Quessep EJ; Yang Y; Lu Y; Song J; Muñoz DF; Li Y; Kurian AW; Kerlikowske K; O'Meara ES; Sprague BL; Tosteson ANA; Feuer EJ; Berry D; Plevritis SK; Huang X; de Koning HJ; van Ravesteyn NT; Lee SJ; Alagoz O; Schechter CB; Stout NK; Miglioretti DL; Mandelblatt JS
JAMA; 2024 Jun; 331(22):1947-1960. PubMed ID: 38687505
[TBL] [Abstract][Full Text] [Related]
8. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.
Trentham-Dietz A; Kerlikowske K; Stout NK; Miglioretti DL; Schechter CB; Ergun MA; van den Broek JJ; Alagoz O; Sprague BL; van Ravesteyn NT; Near AM; Gangnon RE; Hampton JM; Chandler Y; de Koning HJ; Mandelblatt JS; Tosteson AN;
Ann Intern Med; 2016 Nov; 165(10):700-712. PubMed ID: 27548583
[TBL] [Abstract][Full Text] [Related]
9. Benefits and Harms of Mammography Screening for Women With Down Syndrome: a Collaborative Modeling Study.
Alagoz O; Hajjar A; Chootipongchaivat S; van Ravesteyn NT; Yeh JM; Ergun MA; de Koning HJ; Chicoine B; Martin B
J Gen Intern Med; 2019 Nov; 34(11):2374-2381. PubMed ID: 31385214
[TBL] [Abstract][Full Text] [Related]
10. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk.
van Ravesteyn NT; Miglioretti DL; Stout NK; Lee SJ; Schechter CB; Buist DS; Huang H; Heijnsdijk EA; Trentham-Dietz A; Alagoz O; Near AM; Kerlikowske K; Nelson HD; Mandelblatt JS; de Koning HJ
Ann Intern Med; 2012 May; 156(9):609-17. PubMed ID: 22547470
[TBL] [Abstract][Full Text] [Related]
11. Comparing CISNET Breast Cancer Models Using the Maximum Clinical Incidence Reduction Methodology.
van den Broek JJ; van Ravesteyn NT; Mandelblatt JS; Cevik M; Schechter CB; Lee SJ; Huang H; Li Y; Munoz DF; Plevritis SK; de Koning HJ; Stout NK; van Ballegooijen M
Med Decis Making; 2018 Apr; 38(1_suppl):112S-125S. PubMed ID: 29554471
[TBL] [Abstract][Full Text] [Related]
12. Radiation-Induced Breast Cancer Incidence and Mortality From Digital Mammography Screening: A Modeling Study.
Miglioretti DL; Lange J; van den Broek JJ; Lee CI; van Ravesteyn NT; Ritley D; Kerlikowske K; Fenton JJ; Melnikow J; de Koning HJ; Hubbard RA
Ann Intern Med; 2016 Feb; 164(4):205-14. PubMed ID: 26756460
[TBL] [Abstract][Full Text] [Related]
13. Likelihood that a woman with screen-detected breast cancer has had her "life saved" by that screening.
Welch HG; Frankel BA
Arch Intern Med; 2011 Dec; 171(22):2043-6. PubMed ID: 22025097
[TBL] [Abstract][Full Text] [Related]
14. What is the point: will screening mammography save my life?
Keen JD; Keen JE
BMC Med Inform Decis Mak; 2009 Apr; 9():18. PubMed ID: 19341448
[TBL] [Abstract][Full Text] [Related]
15. Implementation of digital mammography in a population-based breast cancer screening program: effect of screening round on recall rate and cancer detection.
Sala M; Comas M; Macià F; Martinez J; Casamitjana M; Castells X
Radiology; 2009 Jul; 252(1):31-9. PubMed ID: 19420316
[TBL] [Abstract][Full Text] [Related]
16. Comparing CISNET Breast Cancer Incidence and Mortality Predictions to Observed Clinical Trial Results of Mammography Screening from Ages 40 to 49.
van den Broek JJ; van Ravesteyn NT; Mandelblatt JS; Huang H; Ergun MA; Burnside ES; Xu C; Li Y; Alagoz O; Lee SJ; Stout NK; Song J; Trentham-Dietz A; Plevritis SK; Moss SM; de Koning HJ
Med Decis Making; 2018 Apr; 38(1_suppl):140S-150S. PubMed ID: 29554468
[TBL] [Abstract][Full Text] [Related]
17. Screening Mammography Efficacy: A Comparison Between Screen-Film, Computed Radiography and Digital Mammography in Taiwan.
Elbakkoush AA; Atique S; Chiang IJ
Stud Health Technol Inform; 2015; 216():914. PubMed ID: 26262216
[TBL] [Abstract][Full Text] [Related]
18. Comparison of direct digital mammography, computed radiography, and film-screen in the French national breast cancer screening program.
Séradour B; Heid P; Estève J
AJR Am J Roentgenol; 2014 Jan; 202(1):229-36. PubMed ID: 24370149
[TBL] [Abstract][Full Text] [Related]
19. Quality-of-life effects of screening mammography in Norway.
Zahl PH; Kalager M; Suhrke P; Nord E
Int J Cancer; 2020 Apr; 146(8):2104-2112. PubMed ID: 31254388
[TBL] [Abstract][Full Text] [Related]
20. Mammography screening and breast cancer mortality in Australia: an aggregate cohort study.
Morrell S; Taylor R; Roder D; Dobson A
J Med Screen; 2012 Mar; 19(1):26-34. PubMed ID: 22345322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
